{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:27:47Z","timestamp":1770899267626,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many old people have at least one chronic disease. As a result, multiple drugs should be used. Gastrointestinal complications may occur because of the harmful effects of these chronic drugs on the stomach. The study aimed to assess the prevalence of upper gastrointestinal complications in patients taking chronic medications, the severity of these symptoms, and whether they take any gastro-protective drugs or not.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>This was a cross-sectional study through face-to-face questionnaires from internal outpatient clinics at a specialized hospital. Patients with chronic diseases who were taking at least one chronic medication were included in the study. Data Collection Form was used to gather information. The Short-Form Leeds Dyspepsia Questionnaire (SF-LDQ) was used to evaluate the severity of the upper gastrointestinal symptoms. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) version 21.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 400 patients with chronic diseases and using multiple medications were included. Among them, 53.8% were females and 56% were married, 58.5% were unemployed, 70% were not smokers, the mean age was 54.7\u2009\u00b1\u200917.5 years. The most common comorbid diseases among the patients were diabetes, hypertension, and arthritis, with percentages of 44.3%, 38%, and 27.3%, respectively. The mean number of chronic medications used was 3.36\u2009\u00b1\u20091.6 with a range of 1 to 9. The most commonly used was aspirin with a percentage of 50%, followed by atorvastatin, bisoprolol, and insulin with percentages of 29.5%, 25%, and 20.3%, respectively. Among the 400 participants, 362 (90.5%) suffered from upper gastrointestinal side effects like indigestion (65.8%), heartburn (78.3%), nausea (48.8%), and regurgitation (52.0%). Based on SF-LDQ scoring, of the 400 respondents, 235(58.8%), 109(27.3%) and 18(4.5%) suffered from mild, moderate and severe dyspepsia, respectively. A high percentage 325 (81.3%) of participants were prescribed gastro-protective medications. Proton pump inhibitors were the most prescribed group in 209 (52.3%) patients. Dyspepsia was significantly associated with older age (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.001), being educated (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.031), not being single (<jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.001), having health insurance (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.021), being a smoker (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.003), and using\u2009\u2265\u20095 medications (<jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Upper gastrointestinal complications among patients with chronic diseases were very common. Fortunately, the symptoms were mild in most cases. The risk increased with age and using a higher number of medications. It is important to review patients\u2019 medications and avoid overuse of them, in addition to use gastro-protective agents when needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-024-03267-y","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:02:06Z","timestamp":1716274926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prevalence and severity of upper gastrointestinal complications among patients with chronic diseases: a cross-sectional study from Palestine"],"prefix":"10.1186","volume":"24","author":[{"given":"Rowa","family":"Al Ramahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deema","family":"Tumeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"issue":"6","key":"3267_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/fampra\/cmu056","volume":"31","author":"L Doos","year":"2014","unstructured":"Doos L, et al. Multi-drug therapy in chronic condition multimorbidity: a systematic review. Fam Pract. 2014;31(6):654\u201363.","journal-title":"Fam Pract"},{"issue":"1","key":"3267_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/fampra\/cml067","volume":"24","author":"U Junius-Walker","year":"2007","unstructured":"Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24(1):14\u20139.","journal-title":"Fam Pract"},{"issue":"4","key":"3267_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","volume":"88","author":"JL Wallace","year":"2008","unstructured":"Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn\u2019t the stomach digest itself? Physiol Rev. 2008;88(4):1547\u201365.","journal-title":"Physiol Rev"},{"key":"3267_CR4","doi-asserted-by":"crossref","unstructured":"Bernell S, Howard SW. Use your words carefully: what is a chronic disease? Front Public Health, 2016. 4(159).","DOI":"10.3389\/fpubh.2016.00159"},{"issue":"2","key":"3267_CR5","first-page":"56","volume":"3","author":"\u015e Arslan","year":"2000","unstructured":"Arslan \u015e, Atalay A, G\u00f6k\u00e7e-Kutsal Y. Drug use in elderly. Turk Geriatri Dergisi. 2000;3(2):56\u201360.","journal-title":"Turk Geriatri Dergisi"},{"key":"3267_CR6","unstructured":"Health PMo. Health Annual Report Palestine 2020. 2020."},{"key":"3267_CR7","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1097\/00005344-200605001-00011","volume":"47","author":"L Laine","year":"2006","unstructured":"Laine L. GI risk and risk factors of NSAIDs. J Cardiovasc Pharmacol. 2006;47:S60\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"3267_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/BF02065549","volume":"40","author":"NJ Talley","year":"1995","unstructured":"Talley NJ, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995;40(6):1345\u201350.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3267_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1756283X15618131","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Therapeutic Adv Gastroenterol. 2016;9(1):98\u2013112.","journal-title":"Therapeutic Adv Gastroenterol"},{"issue":"9","key":"3267_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jsps.2020.07.006","volume":"28","author":"A Alwhaibi","year":"2020","unstructured":"Alwhaibi A, et al. Prevalence and severity of dyspepsia in Saudi Arabia: a survey-based study. Saudi Pharm J. 2020;28(9):1062\u20137.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"3267_CR11","doi-asserted-by":"publisher","first-page":"19844","DOI":"10.1038\/s41598-023-47279-2","volume":"13","author":"AI Aboalrob","year":"2023","unstructured":"Aboalrob AI, et al. Prevalence, awareness, and patterns of non-steroidal anti-inflammatory drug use among health science students in Palestine: a cross-sectional study. Sci Rep. 2023;13(1):19844.","journal-title":"Sci Rep"},{"issue":"4","key":"3267_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2036.2006.03233.x","volume":"25","author":"A Fraser","year":"2007","unstructured":"Fraser A, et al. The short-form leeds dyspepsia questionnaire validation study. Aliment Pharmacol Ther. 2007;25(4):477\u201386.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3267_CR13","first-page":"68","volume":"19","author":"N Farsakh","year":"2000","unstructured":"Farsakh N, et al. Dyspepsia in the general population in Jordan. Indian J Gastroenterology: Official J Indian Soc Gastroenterol. 2000;19(2):68\u201370.","journal-title":"Indian J Gastroenterology: Official J Indian Soc Gastroenterol"},{"key":"3267_CR14","doi-asserted-by":"crossref","unstructured":"Jaber N et al. Dietary and lifestyle factors associated with dyspepsia among pre-clinical medical students in Ajman, United Arab Emirates. Cent Asian J Global Health, 2016. 5(1).","DOI":"10.5195\/cajgh.2016.192"},{"key":"3267_CR15","doi-asserted-by":"publisher","first-page":"100790","DOI":"10.1016\/j.cegh.2021.100790","volume":"11","author":"H Alabdulkareem","year":"2021","unstructured":"Alabdulkareem H, et al. Validation of the arabic version of the short Form Leed\u2019s Dyspepsia Index (SF-LDQ) amongst patients with type II diabetes. Clin Epidemiol Global Health. 2021;11:100790.","journal-title":"Clin Epidemiol Global Health"},{"issue":"4","key":"3267_CR16","first-page":"307","volume":"19","author":"HF Abukhdeir","year":"2013","unstructured":"Abukhdeir HF, et al. Factors affecting the prevalence of chronic diseases in Palestinian people: an analysis of data from the Palestinian Central Bureau of Statistics. East Mediterranean Health J = La Revue De Sante De La Mediterranee Orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2013;19(4):307\u201313.","journal-title":"East Mediterranean Health J = La Revue De Sante De La Mediterranee Orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit"},{"key":"3267_CR17","doi-asserted-by":"crossref","unstructured":"Charlesworth CJ et al. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988\u20132010 The journals of gerontology. Series A, Biological sciences and medical sciences, 2015. 70(8): pp. 989\u2013995.","DOI":"10.1093\/gerona\/glv013"},{"key":"3267_CR18","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0140-6736(21)01526-9","volume":"398","author":"A Najjar","year":"2021","unstructured":"Najjar A, et al. Prevalence of chronic diseases in older Palestinian adults and common pharmacological interventions: a cross-sectional study. Lancet. 2021;398:S40.","journal-title":"Lancet"},{"issue":"sup215","key":"3267_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/00365529609094532","volume":"31","author":"D Armstrong","year":"1996","unstructured":"Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol. 1996;31(sup215):38\u201347.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"3267_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","volume":"64","author":"AC Ford","year":"2015","unstructured":"Ford AC, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049\u201357.","journal-title":"Gut"},{"issue":"1","key":"3267_CR21","doi-asserted-by":"publisher","first-page":"e000387","DOI":"10.1136\/bmjgast-2020-000387","volume":"7","author":"JB Bangamwabo","year":"2020","unstructured":"Bangamwabo JB, et al. Prevalence and sociodemographic determinants of dyspepsia in the general population of Rwanda. BMJ Open Gastroenterol. 2020;7(1):e000387.","journal-title":"BMJ Open Gastroenterol"},{"key":"3267_CR22","doi-asserted-by":"crossref","unstructured":"Bitwayiki R et al. Dyspepsia prevalence and impact on quality of life among Rwandan healthcare workers: a cross-sectional survey. South Afr Med J, 2015. 105(12).","DOI":"10.7196\/SAMJ.2015.v105i12.9482"},{"issue":"12","key":"3267_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-018-0663-4","volume":"20","author":"T Tomita","year":"2018","unstructured":"Tomita T, Oshima T, Miwa H. New approaches to diagnosis and treatment of functional dyspepsia. Curr Gastroenterol Rep. 2018;20(12):1\u20138.","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"3267_CR24","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1017\/S0950268806006030","volume":"134","author":"K Muhsen","year":"2006","unstructured":"Muhsen K, et al. Prevalence and risk factors of Helicobacter pylori infection among healthy 3-to 5-year-old Israeli arab children. Epidemiol Infect. 2006;134(5):990\u20136.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"3267_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2982.2011.01678.x","volume":"23","author":"K Bitar","year":"2011","unstructured":"Bitar K, et al. Aging and gastrointestinal neuromuscular function: insights from within and outside the gut. Neurogastroenterology Motility: Official J Eur Gastrointest Motil Soc. 2011;23(6):490.","journal-title":"Neurogastroenterology Motility: Official J Eur Gastrointest Motil Soc"},{"issue":"5","key":"3267_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.mpmed.2019.02.010","volume":"47","author":"DCR Fernandes","year":"2019","unstructured":"Fernandes DCR, Norman AJ. Drug-induced gastrointestinal disorders. Medicine. 2019;47(5):301\u20138.","journal-title":"Medicine"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03267-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:04:25Z","timestamp":1716275065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3267"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03267-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by An-Najah National University Institutional Review Boards (IRB) and the Hospital administration. A written informed consent was obtained from the patients before starting the interview.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}